Skip to main content

Joan Mary Jasien

Associate Professor of Pediatrics
Pediatrics, Neurology
2301 Erwin Rd, Durham, NC 27710
2301 Erwin Rd, Durham, NC 27710

Overview


Dr. Joan Mary Jasien completed a med-peds residency and neurodevelopmental neurology and became boarded in internal medicine, pediatrics, neurology and is board eligible for neurodevelopment. She is the co-director of the Multidisciplinary Spina Bifida and Cerebral Palsy Related Conditions Clinics and cares for children and adults with neurodevelopmental disabilities at Duke University Medical Center in Durham, NC, USA. Her research focus is on neurological aging in Spina Bifida and other neurodevelopmental disabilities.

Current Appointments & Affiliations


Associate Professor of Pediatrics · 2022 - Present Pediatrics, Neurology, Pediatrics

Recent Publications


Motor function and safety after allogeneic cord blood and cord tissue-derived mesenchymal stromal cells in cerebral palsy: An open-label, randomized trial.

Journal Article Dev Med Child Neurol · December 2022 AIM: To evaluate safety and motor function after treatment with allogeneic umbilical cord blood (AlloCB) or umbilical cord tissue-derived mesenchymal stromal cells (hCT-MSC) in children with cerebral palsy (CP). METHOD: Ninety-one children (52 males, 39 fe ... Full text Open Access Link to item Cite

The microRNA processor DROSHA is a candidate gene for a severe progressive neurological disorder.

Journal Article Hum Mol Genet · August 25, 2022 DROSHA encodes a ribonuclease that is a subunit of the Microprocessor complex and is involved in the first step of microRNA (miRNA) biogenesis. To date, DROSHA has not yet been associated with a Mendelian disease. Here, we describe two individuals with pro ... Full text Open Access Link to item Cite

Characterization of sedation and anesthesia complications in patients with alternating hemiplegia of childhood.

Journal Article Eur J Paediatr Neurol · May 2022 BACKGROUND: Alternating hemiplegia of childhood (AHC) pathophysiology suggests predisposition to sedation and anesthesia complications. GOALS: Hypotheses: 1) AHC patients experience high rates of sedation-anesthesia complications. 2) ATP1A3 mutation genoty ... Full text Link to item Cite
View All Publications

Recent Grants


Guanfacine for Hyperactivity in Children with Down Syndrome

ResearchPrincipal Investigator · Awarded by DCRI-Duke-Site · 2024 - 2025

View All Grants

Education, Training & Certifications


University of Minnesota, Medical School · 2005 M.D.
Vanderbilt University · 1994 M.S.N.